GENE ONLINE|News &
Opinion
Blog

2026-04-08|

Unity and Meta Extend Partnership to Advance Next-Generation VR Technologies

by GOAI
Share To

Unity and Meta have announced the extension of their multi-year partnership aimed at advancing virtual reality (VR) technologies. The collaboration will focus on developing next-generation VR experiences, leveraging Unity’s expertise in real-time 3D development tools and Meta’s capabilities in hardware and immersive platforms.

The extended agreement builds on the companies’ existing relationship, which has centered around creating innovative solutions for VR developers and users. Unity’s tools are widely used by creators to design interactive content, while Meta continues to expand its presence in the VR space through devices like its Quest series. Both companies aim to provide developers with enhanced resources to create immersive applications across gaming, education, training, and other industries. Details regarding specific projects or timelines under this renewed partnership were not disclosed at the time of the announcement.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 8, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Study Finds Non-Communicable Diseases Consume Large Portion of Household Income Among Elderly in India
2026-04-19
Study Identifies Antiviral Compounds in Egyptian Ziziphus spina-christi Effective Against Respiratory Viruses
2026-04-19
10x Genomics Introduces Atera Platform for Single-Cell Analysis and Spatial Biology
2026-04-18
Elevated Fetal Catecholamine Metabolites Linked to Growth Restriction in Sheep Model Study
2026-04-18
White House Issues Executive Order to Boost Research and Access to Psychedelic-Based Mental Health Therapies
2026-04-18
Comorbidities Linked to Higher Risks and Complications in Hip Fracture Surgery Outcomes
2026-04-18
20-Year Study Links Metabolically Healthy Obesity to Increased Long-Term Cardiovascular Disease Risk
2026-04-18
Scroll to Top